Where & When

Monday, November 25, 2024
9 a.m. -2:45 p.m.
HWCRC Auditorium

3-4:30 p.m.
Posters in Elliman Atrium
421 E. Canfield
Cocktail reception follows until 6 p.m.

Registration

Register Now

Lunch will be provided to registered attendees.

Topic & Speakers

“Targeting the metabolic and immunologic vulnerabilities of breast cancer stem cells”

wicha

Max Wicha, M.D.
Madeline and Sidney Forbes Professor of Oncology
Director, Forbes Institute for Cancer Discovery
Founding Director Emeritus, Rogel Cancer Center

Agenda

9-9:10
Welcome – Kay-Uwe Wagner, Ph.D., Leader, Tumor Biology & Microenvironment Program

9:10-9:20
Boris Pasche, M.D., Ph.D. – CEO of Karmanos Cancer Institute and Chair, Department of Oncology, Wayne State Medical School - Welcome and introduction

9:20-9:45
Mike Wilson, Ph.D. – Assistant Professor, Oncology “Epigenetic regulators of early onset endometrial cancer”

9:45-10:10
Izabela Podgorski, Ph.D. – Professor, Pharmacology; Co-leader of Prostate Cancer Research Team “Lipid and iron dynamics in the metastatic bone microenvironment."

10:15-10:30
Break

10:30-10:55
Ben Kidder, Ph.D. – Associate Professor, Oncology “Decoding epigenetic and transcriptional networks in cancer”

11:-11:25
HyeonJoo Cheon, Assistant Professor, Oncology “Non-canonical Roles of PD-L1 in Tumor Progression”

11:30 a.m.-12:30 p.m.
Lunch - HWCRC Auditorium

1-2
Keynote Speaker - Max Wicha, M.D.
Madeline and Sidney Forbes Professor of Oncology Director, Forbes Institute for Cancer Discovery Founding Director Emeritus, Rogel Cancer Center

2-2:30
Eric Sebzda, Ph.D. – Associate Professor, Biochemistry, Microbiology and Immunology “A targetable subset of T cells is necessary for tumor progression towards malignancy”

2:45-4
Poster Presentations at Louis Elliman Atrium, 421 E. Canfield

4-6
Cocktail Reception

Contact Us

For more information, please contact J'nice Stork at storkj@karmanos.org.

The Latest From Karmanos Cancer Institute

News

IN THE NEWS: Detroit Cancer Center Unveils New Device for Treating Liver Cancer at Home

The Detroit News The TheraBionic P1 device is now available for patients who have advanced liver cancer and have failed first- and second-line the...

Read More

Karmanos Cancer Institute Physicians Begin Prescribing New FDA-approved Radiofrequency Electromagnetic Device to Treat Advanced Liver Cancer

The Barbara Ann Karmanos Cancer Institute , the largest provider of cancer care and research in Michigan and part of McLaren Health Care, announce...

Read More

CURE, in Collaboration with Karmanos' Office of Cancer Health Equity and Community Engagement, Educates the Community About Metastatic Breast Cancer

On Wednesday, Dec. 4, 2024, patients, survivors, and advocates gathered at Karmanos Cancer Institute in Detroit to learn about metastatic breast c...

Read More
News

WDET | Scholarship Program Aims to Encourage More Diversity in Clinical Trials

Listen Now

101 WRIF | Lung Cancer Awareness

Listen Now

Becker’s Healthcare Podcast | Exploring Breakthroughs in Cancer Treatment with Dr. Boris C. Pasche, President & CEO at Karmanos Cancer Institute

Listen Now